INTRAGLY-FORTE
MRP: 395
Packaging: 30 Caps
Pack Type: life-caps
Composition:
Glycopyrronium, Formoterol Fumarate and Budesonide Powder for Inhalation 25 mcg, 12 mcg and 400 mcg
Indication:
for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. This combination of medications is used to improve lung function, reduce symptoms such as shortness of breath, and decrease the frequency of COPD exacerbations.
Description:
This Triple Drug Combination Inhaler contains:
Glycopyrronium 25 mcg: A Long-Acting Muscarinic Antagonist (LAMA)
Formoterol Fumarate 12 mcg: A Long-Acting Beta-2 Agonist (LABA)
Budesonide 400 mcg: An Inhaled Corticosteroid (ICS)
It offers comprehensive control of chronic airway diseases by combining bronchodilation with anti-inflammatory action. Indicated for patients with moderate to severe COPD and those with severe asthma not controlled by LABA/ICS alone, it helps in reducing symptoms, improving lung function, and preventing exacerbations.
Tags:
- Provides comprehensive symptom control
- Reduces exacerbation risk and hospitalizations
- Offers dual bronchodilation + anti-inflammation
- Improves exercise tolerance and quality of life Once or twice daily dosing for better compliance
Usage Information
Dosage
Recommended Dose: 1 inhalation twice daily (or as directed) Administration: Use with a dry powder inhaler (DPI) device Rinse mouth after use to prevent oral thrush Do not exceed the prescribed dose
Side Effects
Oral candidiasis (thrush) Hoarseness of voice Headache Tremors or palpitations Dry mouth or throat irritation Cough or increased sputum production
Contraindications
Hypersensitivity to any of the three components Patients with acute asthma or COPD attacks Use with caution in cardiac arrhythmias, hypertension, glaucoma, and urinary retention Not recommended for children under 18 unless prescribed